Parkinson's Disease Trial, Recruiting NCT06602544 Sponsor: Harvard Medical School (HMS and HSDM) Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT06602544
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Be between 18 and 90 years old
  • Have freezing of gait (sudden inability to move your feet while walking) caused by Parkinson's disease, based on your own report
  • Score 21 or higher on a standard memory and thinking test called the MoCA
  • Be able to walk at least 20 meters (about 65 feet) on your own, even if you use a walking aid like a cane or walker, without needing someone to physically help you
  • Be able to speak, understand, and communicate clearly with the study team
  • Be willing to allow the study team to contact your doctor to confirm your medical history if needed
  • Be willing to sign a consent form agreeing to take part in the study
  • Be able to attend 8 research visits

Who may not be able to join:

  • Had more than 2 falls in the past month due to walking difficulties (though the study doctor may still allow you to join)
  • Had a major surgery in the last 6 months that affects your ability to walk (though the study doctor may still allow you to join)
  • Have walking difficulties caused by a missing limb
  • Experience ongoing, long-term pain that affects your ability to walk (though the study doctor may still allow you to join)
  • Have serious health conditions unrelated to walking — such as uncontrolled heart, nerve, skin, or blood vessel problems (for example, untreated blood clots) — that could interfere with taking part in the study
  • Do not show noticeable freezing of gait that can be observed by the study team

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Terry Ellis, PT, PhD, Boston University

Phone: 617-353-7525

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Harvard Medical School (HMS and HSDM)
Registry
ClinicalTrials.gov
Start date
3 September 2024
Est. completion
1 September 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in percent time spent freezing; Change in percent time spent freezing; Change in percent time spent freezing; Change in percent time spent freezing; Change in percent time spent freezing; Change in percent time spent freezing; Change in stride length; Change in stride length; Change in stride length; Change in stride length; Change in stride length; Change in stride length

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov